CY1117502T1 - ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE - Google Patents

ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE

Info

Publication number
CY1117502T1
CY1117502T1 CY20151101082T CY151101082T CY1117502T1 CY 1117502 T1 CY1117502 T1 CY 1117502T1 CY 20151101082 T CY20151101082 T CY 20151101082T CY 151101082 T CY151101082 T CY 151101082T CY 1117502 T1 CY1117502 T1 CY 1117502T1
Authority
CY
Cyprus
Prior art keywords
methods
ceacam1 antibodies
antibodies
ceacam1
disclosed
Prior art date
Application number
CY20151101082T
Other languages
Greek (el)
Inventor
Gal Markel
Rona Ortenberg
Jacob Schachter
Original Assignee
Tel Hashomer Medical Research Infrastructure And Services Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10721207.8A external-priority patent/EP2424896B1/en
Application filed by Tel Hashomer Medical Research Infrastructure And Services Ltd. filed Critical Tel Hashomer Medical Research Infrastructure And Services Ltd.
Publication of CY1117502T1 publication Critical patent/CY1117502T1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Αποκαλύπτεται ένα κύτταρο υβριδώματος το οποίο έχει αποτεθεί στην ATCC με Αριθμό Προσθήκης ΡΤΑ-9974. Επίσης παρέχονται Αντισώματα και μεθόδοι χρήσης αυτών.A hybridoma cell disclosed in the ATCC with Accession Number PTA-9974 is disclosed. Antibodies and methods of their use are also provided.

CY20151101082T 2009-04-30 2015-11-27 ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE CY1117502T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21304009A 2009-04-30 2009-04-30
EP10721207.8A EP2424896B1 (en) 2009-04-30 2010-04-29 Anti ceacam1 antibodies and methods of using same

Publications (1)

Publication Number Publication Date
CY1117502T1 true CY1117502T1 (en) 2017-04-26

Family

ID=58606620

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151101082T CY1117502T1 (en) 2009-04-30 2015-11-27 ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE

Country Status (1)

Country Link
CY (1) CY1117502T1 (en)

Similar Documents

Publication Publication Date Title
CY1121911T1 (en) CD47 ANTIBODIES AND METHODS OF USING THEM
CL2019002036A1 (en) Antibody against bcma and its use.
CY1121862T1 (en) ANTI-PHF-TAU ANTIBODIES AND USES THEREOF
CL2018000263A1 (en) Bispecific antibody constructs that bind to egfrviii and cd3.
CL2018000270A1 (en) Antibody constructs for cd70 and cd3.
CL2018000268A1 (en) Bispecific antibody constructs that bind mesothelin and cd3
CL2018000269A1 (en) Antibody constructs for flt3 and cd3
CO6720984A2 (en) Anti-mesothelin and immunoconjugate antibodies
ECSP10010438A (en) ANTI-CD79b ANTIBODIES AND IMMUNOCADES AND METHODS OF USE
CL2015000582A1 (en) Anti-mcam antibodies and associated methods of use
CO6721041A2 (en) Anti-pcsk9 antibody and methods of use
UY34411A (en) IMMUNO LINKERS AGAINST SCLEROSTINE
TR201910320T4 (en) Culture method for liver organoid, their use and obtaining.
CO6771458A2 (en) Antibody-drug conjugates
GT201200096A (en) MONOCLONAL ANTIBODIES
BR112012024049A2 (en) rna interference on dermal and fibrotic indications
NZ702680A (en) Anti-gd2 antibodies
CR20110576A (en) ANTI-EGFL7 HUMANIZED ANTIBODIES AND METHODS OF USE OF THE SAME
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
EP2566890A4 (en) Anti-pai-1 antibodies and methods of use thereof
CO6680644A2 (en) Modified ralaxin polypeptides and their uses
UY34167A (en) PIRROLOTRIAZINS REPLACED WITH HYDROXIMETHYLARY AND ITS USES
MX340555B (en) Antibodies against il-18r1 and uses thereof.
MX336323B (en) Anti-polyubiquitin antibodies and methods of use.
CY1117502T1 (en) ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE